Safety and Efficacy of Remote Ischemic Conditioning in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy

Status: Recruiting
Location: See location...
Intervention Type: Device, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Revascularization surgery has been the standard treatment to prevent ischemic stroke in pediatric Moyamoya disease (MMD) patients with ischemic symptoms. However, perioperative complications, such as hyperperfusion syndrome, new infarct on imaging, or ischemic stroke, are inevitable. Remote ischemic conditioning (RIC) is a noninvasive and easy-to-use neuroprotective strategy, and it has potential effects on preventing hyperperfusion syndrome and ischemic infarction.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:

• Age: ≥0 and ≤18

• All of the patients underwent digital subtraction angiography and met the current diagnostic criteria recommended by the Research Committee on MMD (Spontaneous Occlusion of the Circle of Willis) of the Ministry of Health and Welfare of Japan in 2012

• Suzuki stages concentrated in Stage III and IV

• Presentation with ischemic symptoms, such as transient ischemic attack (TIA), headache, seizure, hemorrhagic stroke, and ischemic stroke confirmed by MRI

• Informed consent obtained from patient or acceptable patient's surrogate

Locations
Other Locations
China
The Fifth Medical Center of Chinese PLA General Hospital
RECRUITING
Beijing
Contact Information
Primary
Xunming Ji, MD PhD
807595234@qq.com;
+8613911077166
Backup
Sijie Li, MD
phoenix0537@sina.com
+8613581610258
Time Frame
Start Date: 2024-09-10
Estimated Completion Date: 2025-02-28
Participants
Target number of participants: 42
Treatments
Experimental: RIC group
Patients allocated to the RIC group will undergo RIC procedure during which bilateral arm cuffs are inflated to a pressure of 50 mmHg over systolic blood pressure for five cycles of 5 min followed by 5 min of relaxation of the cuffs.They will also accept medication treatment by professional neurologists.
Other: Medication group
Patients allocated to the medication group will accept medication treatment by professional neurologists.
Related Therapeutic Areas
Sponsors
Collaborators: The Fifth Medical Center of the Chinese People's Liberation Army (PLA) General Hospital
Leads: Capital Medical University

This content was sourced from clinicaltrials.gov